Vivaldi Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-8,331
| Closed | -$234K | – | 178 |
|
|
2026
Q1 | $234K | Buy |
+8,331
| New | +$222K | 0.03% | 254 |
|
|
2025
Q3 | – | Sell |
-14,438
| Closed | -$350K | – | 304 |
|
|
2025
Q2 | $350K | Buy |
14,438
+472
| +3% | +$11K | 0.05% | 202 |
|
|
2025
Q1 | $354K | Sell |
13,966
-34
| -0.2% | -$890 | 0.06% | 188 |
|
|
2024
Q4 | $376K | Sell |
14,000
-109
| -0.8% | -$2.96K | 0.06% | 179 |
|
|
2024
Q3 | $408K | Buy |
14,109
+329
| +2% | +$9.6K | 0.12% | 127 |
|
|
2024
Q2 | $386K | Sell |
13,780
-5,178
| -27% | -$143K | 0.11% | 145 |
|
|
2024
Q1 | $531K | Sell |
18,958
-965
| -5% | -$26.8K | 0.15% | 118 |
|
|
2023
Q4 | $537K | Sell |
19,923
-1,315
| -6% | -$39.8K | 0.16% | 116 |
|
|
2023
Q3 | $704K | Sell |
21,238
-369
| -2% | -$13K | 0.23% | 93 |
|
|
2023
Q2 | $793K | Buy |
21,607
+734
| +4% | +$28.6K | 0.24% | 88 |
|
|
2023
Q1 | $852K | Sell |
20,873
-23,501
| -53% | -$1.02M | 0.26% | 82 |
|
|
2022
Q4 | $2.15M | Buy |
44,374
+2,272
| +5% | +$109K | 0.53% | 59 |
|
|
2022
Q3 | $1.78M | Sell |
42,102
-248
| -0.6% | -$12.1K | 0.48% | 60 |
|
|
2022
Q2 | $2.22M | Buy |
42,350
+4,527
| +12% | +$231K | 0.58% | 50 |
|
|
2022
Q1 | $1.89M | Sell |
37,823
-495
| -1% | -$25.7K | 0.49% | 55 |
|
|
2021
Q4 | $2.26M | Sell |
38,318
-78
| -0.2% | -$3.87K | 0.52% | 47 |
|
|
2021
Q3 | $1.65M | Sell |
38,396
-248
| -0.6% | -$11K | 0.36% | 62 |
|
|
2021
Q2 | $1.87M | Sell |
38,644
-256
| -0.7% | -$9.96K | 0.38% | 58 |
|
|
2021
Q1 | $1.56M | Sell |
38,900
-6,004
| -13% | -$213K | 0.31% | 71 |
|
|
2020
Q4 | $1.65M | Sell |
44,904
-2,425
| -5% | -$89K | 0.35% | 63 |
|
|
2020
Q3 | $1.73M | Sell |
47,329
-1,605
| -3% | -$56.3K | 0.39% | 61 |
|
|
2020
Q2 | $1.78M | Sell |
48,934
-1,798
| -4% | -$61.1K | 0.37% | 60 |
|
|
2020
Q1 | $1.57M | Sell |
50,732
-594
| -1% | -$20.2K | 0.35% | 57 |
|
|
2019
Q4 | $1.91M | Buy |
51,326
+99
| +0.2% | +$3.53K | 0.46% | 49 |
|
|
2019
Q3 | $1.75M | Buy |
51,227
+1,597
| +3% | +$58.1K | 0.41% | 52 |
|
|
2019
Q2 | $2.04M | Buy |
49,630
+29,663
| +149% | +$1.18M | 0.53% | 46 |
|
|
2019
Q1 | $805K | Buy |
19,967
+8,271
| +71% | +$331K | 0.22% | 104 |
|
|
2018
Q4 | $484K | Buy |
11,696
+3,991
| +52% | +$166K | 0.21% | 90 |
|
|
2018
Q3 | $322K | Buy |
7,705
+52
| +0.7% | +$2K | 0.17% | 93 |
|
|
2018
Q2 | $263K | Sell |
7,653
-920
| -11% | -$31.4K | 0.22% | 107 |
|
|
2018
Q1 | $289K | Buy |
8,573
+472
| +6% | +$16.2K | 0.22% | 103 |
|
|
2017
Q4 | $278K | Buy |
8,101
+70
| +0.9% | +$2.39K | 0.23% | 96 |
|
|
2017
Q3 | $272K | Buy |
8,031
+8,023
| +100,288% | +$258K | 1.17% | 47 |
|
|
2017
Q2 | $253 | Sell |
8
-7,931
| -100% | -$250K | ﹤0.01% | 74 |
|
|
2017
Q1 | $258 | Buy |
+7,939
| New | +$250K | ﹤0.01% | 118 |
|
Other funds holding PFE
Vivaldi Capital Management's PFE Position: Q2 2026 in Review
Vivaldi Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,331 shares — an estimated $234K sold.
Vivaldi Capital Management first reported a position in PFE in Q1 2017 and held it in 35 quarters. The position peaked at $2.26M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Vivaldi Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Vivaldi Capital Management sold 8,331 Pfizer shares in Q2 2026, an estimated $234K.
- Vivaldi Capital Management first reported a position in Pfizer in Q1 2017 and held it in 35 quarters.
- Vivaldi Capital Management's Pfizer position peaked at $2.26M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Vivaldi Capital Management's 13F filing for Q2 2026.